CMPX — COMPASS THERAPEUTICS INC

Ownership history in ACT Advisors, LLC.  ·  4 quarters on record

This page tracks every 13F SEC filing in which ACT Advisors, LLC. reported a position in COMPASS THERAPEUTICS INC (CMPX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2025 Q3)
Avg. % of fund
0.01%
First filed
2024 Q4
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 10,376 — 0% 0.01% $36K $3.50
2025 Q2 REDUCED 10,376 -385 -3.6% 0.01% $27K $2.60
2025 Q1 ADDED 10,761 +233 +2.2% 0.01% $20K $1.90
2024 Q4 INITIATED 10,528 — — 0.01% $15K $1.45
% of Fund (quarterly)    CMPX price (monthly, adj. close)

Other funds also holding CMPX

As of 2025 Q4 — sorted by position size

Birchview Capital, LP 3Y 7Y 5.01% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 4.45% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 3.99% CAXTON CORP 3Y 7Y 3.7% Vivo Capital, LLC 3Y 7Y 3.31% Monashee Investment Management LLC 3Y 7Y 3.03% Seven Fleet Capital Management LP 2.32% Palo Alto Investors LP 3Y 7Y 1.89% ORBIMED ADVISORS LLC 3Y 7Y 1.67% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 1.56%
← Back to ACT Advisors, LLC. Holdings